Purchase Order HHSN271201200220P
Award Date
2/2/12
Potential Completion Date
4/15/12
Potential Value
$90K
Federal Agency
National Institute on Drug Abuse
Awardee
Patheon API Services, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6850 - Miscellaneous Chemical Specialties
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Florence, SC 29501, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $702,848.85 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for dosage form development, manufacturing, and stability studies of a drug product called R-VK4-116, with a period of performance from June 1, 2021 to May 31, 2025. The contract is not set aside for any specific business category. The contract was awarded to Societal CDMO San Diego,...
This is a firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The $748,487.00 contract is for the development, manufacture, and stability studies of the drug product NCGC72. It was awarded under the NCATS Drug Product Development Studies 2017-2022 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract does not...
<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>
<p>This is a $493,000.00 firm fixed price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Catalent Maryland, Inc. (doing business as Paragon Biosciences). The contract does not have a set-aside designation. The contract supports work related to NIDA's programs, with an ultimate completion date of September 27, 2017. Catalent Maryland, Inc. is the prime contractor for this award.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $87,672.00 Firm Fixed Price Purchase Order contract to Glixx Laboratories, Inc., a self-certified small disadvantaged business. The contract is part of the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, and has an ultimate completion date of November 30, 2015. The contract does not have a set-aside designation.</p>
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract provides for the synthesis and delivery of 0.2 grams of the small molecule Marizomib, with a purity of 95% or above, as well as a report detailing the synthesis and purity information. The contract has a ceiling value of $10,800.00 and a performance period of approximately 20 weeks from...
This is a $760,749 firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The order is to provide dosage form development, manufacturing, and stability studies of the investigational drug ORC-13661 for a Phase II clinical trial. This delivery order was issued under the NCATS Drug Product Development Studies 2017-2022 indefinite...
This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
This is a firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to JM Sisco Pharma Consulting, LLC, a small business entity. The contract, valued at $85,030.20, is for pharmaceutical consulting services related to chemical manufacturing and controls. The contract is part of the Drug Consulting Blueprint Network vehicle, which the contractor has consistently used to...